Skip to main content
. 2014 Nov 18;1:44. doi: 10.3389/fmed.2014.00044

Figure 1.

Figure 1

Schematic overview of the pretargeting strategy. First, tumors are pretargeted with bispecific antibodies (bsAb). Secondly, small radiolabeled hapten peptide is i.v. injected and binds to the pretargeted bsAb at the tumor cells.